Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

Arxis, Inc.
Next earnings ≈ Aug 27, 2026 · est. from filing cadence
Last earnings +17.8% on 2026-05-28
Fast-growing, newly profitable aerospace-parts roll-up, but $2.65B of debt and a goodwill/intangible-heavy balance sheet temper the story.
Arxis is an aerospace parts and equipment business (recently public, reporting on a combined basis) showing strong operating momentum. Q1 2026 revenue grew to $458,858K from $380,079K a year ago, and the company swung to net income of $53,309K from a $4,324K loss. The improvement is broad-based: gross profit rose to $234,843K (a margin near 51%) from $162,911K, operating income nearly doubled to $110,503K, and interest expense fell sharply to $43,958K from $68,260K as last year's figure reflected refinancing costs (including a $15,535K loss on extinguishment of debt in the prior period). That deleveraging of the income statement is the key driver of the profit swing.
Sources: SEC EDGAR (CIK 0002093536, latest 10-Q filed 2026-05-28) · EODHD · analysis by claude-code · as of 6/21/2026, 8:43:12 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1482 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Last 90 days: 7 open-market buys · 0 sales
| 2026-04-17 | Jankowski Ryan Anthony Chief Accounting Officer | Buy | 4.46K @ $28.00 | $125K |
| 2026-04-17 | Badakhsh Azad Sid See Remarks | Buy | 36.0K @ $28.00 | $1.01M |
| 2026-04-17 | Sealfon Ross Bradley See Remarks | Buy | 12.5K @ $28.00 | $350K |
| 2026-04-17 | Oetgen Stephen Duane Director | Award | 5.36K | |
| 2026-04-17 | Oetgen Stephen Duane Director | Buy | 25.0K @ $28.00 | $700K |
| 2026-04-17 | ALLEN PATRICK E Director | Award | 5.36K | |
| 2026-04-17 | ALLEN PATRICK E Director | Buy | 10.0K @ $28.00 | $280K |
| 2026-04-17 | Perhamus Kevin Scott See Remarks | Buy | 53.6K @ $28.00 | $1.50M |
| 2026-04-17 | Roth Jason Aaron See Remarks | Buy | 60.0K @ $28.00 | $1.68M |
| 2026-04-16 | Jankowski Ryan Anthony Chief Accounting Officer | Award | 46.9K | |
| 2026-04-16 | Allen Jennifer H. See Remarks | Award | 53.7K | |
| 2026-04-16 | Badakhsh Azad Sid See Remarks | Award | 368K |